INTERNATIONAL PATENT: ASCLETIS PHARMA (CHINA) CO., LIMITED FILES APPLICATION FOR "THR-BETA MODULATORS, ALONE OR IN COMBINATION WITH GLP-1RGIPRGCGR MODULATORS FOR THE TREATMENT OF METABOLIC DISEASES AND ALOPECIA AREATA DISEASES"

GENEVA, May 10 -- ASCLETIS PHARMA (CHINA) CO., LIMITED (Room 1903, 19/F, Lee Garden One33 Hysan Avenue, Causeway BayHong Kong) filed a patent application (PCT/CN2025/131243) for "THR-BETA MODULATORS, ALONE OR IN COMBINATION WITH GLP-1RGIPRGCGR MODULATORS FOR THE TREATMENT OF METABOLIC DISEASES AND ALOPECIA AREATA DISEASES" on Oct 30, 2025. With publication no. WO/2026/092583, the details related to the patent application was published on May 07, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WU, Jinzi Jason (Room 1903, 19/F, Lee Garden One33 Hysan Avenue, Causeway BayHong Kong)

Abstract: P...